retatrutide unauthorized sales ⚠️ BEWARE OF SOLD ONLINE! There are many "miracle" weight loss solutions spreading on social media, but not all are safe. Retatrutide is still undergoing clinical trials and NO FDA APPROVAL October 27, 2025: U.K. regulators

Cresto JC, Fabiano de Bruno LE, Cao GF, Pastorale CF, Confalonieri N, del Carmen Camberos M et al

AOD 9604 AOD 9604 is a peptide fragment of the C-terminus of Human Growth Hormone (hGH)

Hepatology 60(2):715735

The most directly comparable options are other approved incretin therapies tirzepatide, liraglutide, dulaglutide, and exenatide

Clinical trial data shows that discontinuing tirzepatide typically results in weight regain, so long-term use appears necessary for sustained outcomes

Those Recovering From Injury When stacked with recovery-enhancing peptides like BPC157 or TB500, CJC1295 can support tissue regeneration, reduce inflammation, and speed up recovery timelines